Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | BTK |
| Variant | C481A |
| Impact List | missense |
| Protein Effect | unknown |
| Gene Variant Descriptions | BTK C481A lies within the protein kinase domain of the Btk protein (UniProt.org). C481A interferes with drug binding, leading to ibrutinib resistance (PMID: 24869597, PMID: 29875397), but has not been biochemically characterized and therefore, its effect on Btk protein function is unknown (PubMed, Jun 2025). |
| Associated Drug Resistance | Y |
| Category Variants Paths |
BTK mutant BTK C481X BTK C481A |
| Transcript | NM_000061.3 |
| gDNA | chrX:g.101356176_101356177delTGinsGC |
| cDNA | c.1441_1442delTGinsGC |
| Protein | p.C481A |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_000061.3 | chrX:g.101356176_101356177delTGinsGC | c.1441_1442delTGinsGC | p.C481A | RefSeq | GRCh38/hg38 |
| NM_000061.2 | chrX:g.101356176_101356177delTGinsGC | c.1441_1442delTGinsGC | p.C481A | RefSeq | GRCh38/hg38 |
| NM_000061 | chrX:g.101356176_101356177delCAinsGC | c.1441_1442delTGinsGC | p.C481A | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| BTK C481A | chronic lymphocytic leukemia | predicted - resistant | Ibrutinib | Preclinical | Actionable | In a preclinical study, patients with BTK C481 were predicted to have resistance to Imbruvica (ibrutinib) since C481 is in the covalent binding site of the BTK inhibitor and C481A interferes with drug binding (PMID: 24869597). | 24869597 |